Vitamin D Deficiency in Cardiovascular and Renal Disease: New Light Shed on an Old Enemy

Current Drug Targets

Volumn 12, Issue 1, 2011, Pages 1-3

  de Borst, Martin H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D DERIVATIVE; DRUG DERIVATIVE;

ATHEROSCLEROSIS; BONE DEFORMATION; BONE METABOLISM; CARDIOVASCULAR DISEASE; EDITORIAL; ENDEMIC DISEASE; HEART PROTECTION; HUMAN; KIDNEY DISEASE; METABOLITE; NUTRITIONAL DEFICIENCY; RENAL PROTECTION; RICKETS; RISK FACTOR; UNITED KINGDOM; VASCULARIZATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANIMAL; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79953211143     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011793591644     Document Type: Editorial

References (16)

1. Hess AF. Rickets Including Osteomalacia and Tetany. Philadelphia, PA: Lea & Febiger 1929.
2. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003; 112: e132-5.
3. Hess AF, Unger LJ, Pappenheimer AM. Experimental rickets in rats. III. The prevention of rickets in rats by exposure to sunlight. J Biol Chem 1922; 50.
4. Huldschinsky K. Heilung von Rachitis durch Künstliche Höhensonne. Deutsche med Wochenschrift 1919; 45: 712-3.
5. McCollum EV, Simmonds N, Becker JE, Shipley PG. Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922; 53: 293-312.
6. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
7. Holick MF. Vitamin D: Evolutionary, Physiological and Health Perspectives. Curr Drug Targets 2011; 12(1): 4-18.
8. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011; 12(1): 19-28.
9. Meems LMG, Van der Harts P, Van Gilst WH, De Boer RA. Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets 2011; 12(1): 29-41.
10. Brewer LC, Michos ED, Reis JP. Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function. Curr Drug Targets 2011; 12(1): 54-60.
11. Boucher BJ. Vitamin D and diabetes. Curr Drug Targets 2011; 12(1): 61-87.
12. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 2008; 105: 15896-901.
13. Doorenbos CR, van den Born J, Navis G, de Borst MH. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 2009; 5: 691-700.
14. Mirkoviæ K, van den Born J, Navis G, de Borst MH. Vitamin D in chronic kidney disease: new potential for intervention. Curr Drug Targets 2011; 12(1): 42-53.
15. Pilz S, Tomaschitz A, Drechsler C, Zitterman A, Dekker JM, Marz W. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 2011; 12(1): 88-96.
16. de Borst MH, De Boer RA, Stolk RP, Slaets JPJ, Wolffenbuttel BHR, Navis GJ. Vitamin D deficiency: universal risk factor for multifactorial diseases? Curr Drug Targets 2011; 12(1): 97-106.